|
Volumn 73, Issue 2, 1994, Pages 437-444
|
Combined antineoplastic and antiretroviral therapy for patients with hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients
|
Author keywords
antineoplastic; antiretroviral; Hodgkin's disease; human immunodeficiency virus infection; therapy
|
Indexed keywords
BLEOMYCIN;
EPIRUBICIN;
VINBLASTINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
ARTICLE;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HODGKIN DISEASE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN TISSUE;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
OPPORTUNISTIC INFECTION;
PRIORITY JOURNAL;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
DRUG THERAPY, COMBINATION;
EPIRUBICIN;
FEMALE;
HIV INFECTIONS;
HODGKIN DISEASE;
HUMANS;
LYMPHOMA, AIDS-RELATED;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
VINBLASTINE;
ZIDOVUDINE;
|
EID: 0028054668
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/1097-0142(19940115)73:2<437::AID-CNCR2820730232>3.0.CO;2-2 Document Type: Article |
Times cited : (57)
|
References (25)
|